Hypertrophic Cardiomyopathy Therapeutics Market Hypertrophic Cardiomyopathy Therapeutics Market : ToC


Hypertrophic Cardiomyopathy Therapeutics Market

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

  • Rep Id : TMRGL7553
  • Published On : Nov 2015
  • No. of Pages : 78
  • Category : Pharmaceutical

 

1. Preface
     1.1. Report Description
     1.2. Market Segmentation
     1.3. Research Methodology

2. Executive Summary
     2.1. Hypertrophic Cardiomyopathy Therapeutics: Market Snapshot
     2.2. Global Hypertrophic Cardiomyopathy Therapeutics Market Share, by Geography, 2014 & 2023 (Value %)
     2.3. Global Hypertrophic Cardiomyopathy Therapeutics Market, by Drug Class, 2014 (US$ Mn)

3. Hypertrophic Cardiomyopathy Therapeutics Market - Industry Analysis
     3.1. Introduction
     3.2. Epidemiology and Prognosis: Hypertrophic Cardiomyopathy
     3.3. Market Dynamics
            3.3.1. Drivers
                     3.3.1.1. Driver 1: Increasing prevalence of chronic cardiovascular diseases to increase demand for effective treatments
                     3.3.1.2. Driver 2: High awareness associated with HCM in developed countries
            3.3.2. Restraints
                     3.3.2.1. Restraint 1: Rising technological upgradation in devices such as defibrillators and pacemakers
            3.3.3. Opportunities
                     3.3.3.1. Opportunity 1: Targeted therapy for hypertrophic cardiomyopathy
     3.4. Market Attractiveness Analysis - Hypertrophic Cardiomyopathy Therapeutics Market, by Geography, 2014
     3.5. Competitive Landscape 
     3.6. Global Hypertrophic Cardiomyopathy Therapeutics Market Share, by Key Players, 2014 (%)

4. Market Segmentation – By Drug
     4.1. Introduction
            4.1.1. Global Hypertrophic Cardiomyopathy Therapeutics Market Revenue, by Drug Class, 2013–2023 (US$ Mn)
     4.2. Global Beta Adrenergic Blocking Agents Market Revenue, 2013–2023 (US$ Mn) and Analysis
     4.3. Global Calcium Channel Blockers Market Revenue, 2013–2023 (US$ Mn) and Analysis
     4.4. Global Antiarrhythmic Agents Market Revenue, 2013–2023 (US$ Mn) and Analysis
     4.5. Global Anticoagulants  Market Revenue, 2013–2023 (US$ Mn) and Analysis

5. Pipeline Analysis
     5.1. Overview
     5.2. Phase II and Phase I Clinical Trials

6. Market Segmentation – By Geography
     6.1. Introduction
            6.1.1. Global Hypertrophic Cardiomyopathy Therapeutics Market Revenue, by Region, 2013–2023 (US$ Mn)
     6.2. North America Hypertrophic Cardiomyopathy Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
            6.2.1. U.S. Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
            6.2.2. Canada Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
     6.3. Europe Hypertrophic Cardiomyopathy Therapeutics Market – Revenue, by Country, 2013–2023 (US$ Mn)
            6.3.1. U.K. Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
            6.3.2. Germany Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
            6.3.3. Rest of Europe Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
     6.4. Asia Pacific Hypertrophic Cardiomyopathy Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
            6.4.1. India Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
            6.4.2. Japan Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
            6.4.3. Rest of APAC Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
     6.5. Rest of the World Hypertrophic Cardiomyopathy Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
            6.5.1. Latin America Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
            6.5.2. Middle East Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)
            6.5.3. Africa Hypertrophic Cardiomyopathy Therapeutics Market Revenue, 2013–2023, (US$ Mn)

7. Recommendations
     7.1. Recommendation 1: Companion diagnostics would help to increase the diagnostic rate and ultimately the drugs market 

8. Company Profiles
     8.1. Astra Zeneca plc
     8.2. Concordia Healthcare Corp.
     8.3. Gilead Sciences, Inc.
     8.4. Merck & Co., Inc.
     8.5. Mylan N.V.
     8.6. Novartis AG
     8.7. Pfizer, Inc. 
     8.8. Sanofi S.A.
     8.9. Teva Pharmaceutical Industries Ltd